During this segment, the panelists further discuss patient-centered care and explore the challenges that managed care stakeholders face as they attempt to establish new payment models that link reimbursement to measures of overall performance and outcomes of care.
As patient-centered care becomes the new standard, changes in the overall payment structure are expected to happen very quickly, explains Scott Gottlieb, MD. Although linking compensation to actual clinical care is a challenge, Dr Gottlieb and Brian Kiss, MD, suggest that patient-reported outcomes can be useful when establishing a new payment model.
Dr Kiss suggests that patient-reported outcomes (eg, adverse events) should be evaluated rather than patients’ functional statuses as determined by clinicians. Patient reports generally describe adverse events in much greater detail than physicians’ assessments do.
Government agencies should focus on assessing experiences and outcomes from the patients’ perspectives, adds Dr Gottlieb, as measuring what is happening in the clinical setting can be challenging.
Michael Kolodziej, MD, and Ted Okon, MBA, note that private payers are leading the way in payment reform. Mr Okon notes that while government programs are using antiquated systems incapable of bringing all the data together for use in evaluating quality, private payers are taking the lead in terms of combing data to evaluate outcomes.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Many Patients With Psoriasis in Clinical Trials Experience Nocebo Effects, Study Finds
April 18th 2024Half of patients exposed to placebo in clinical trials experienced adverse events (AEs), which may be partially explainable by nocebo effects, according to a recent review and meta-analysis.
Read More
Low-Volume Hospitals Had Higher Reoperation Rate, Postoperative Complications in CRC
April 18th 2024Patients opting for elective colorectal surgery to address colorectal cancer (CRC) could have different rates of reoperation and postoperative complications based on the size of the hospital.
Read More